Acute searching and early diagnosis of HCV infected persons

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis C virus (HCV) infection remains a significant global health issue, impacting approximately 71 million individuals worldwide.
• People who inject drugs (PWID) represent the primary demographic for chronic HCV infection, often due to intravenous drug use.
• Direct-acting antivirals (DAA) offer highly effective treatment, achieving nearly 100% efficacy for HCV infection.

Purpose of the Study:

• To highlight the challenges in diagnosing HCV infection among people who inject drugs (PWID).
• To emphasize the need for evolving diagnostic and treatment strategies for chronic hepatitis C.
• To evaluate the effectiveness of outreach testing and collaborative approaches for HCV elimination in the PWID population.

Main Methods:

• Review of current strategies for HCV diagnosis and treatment.
• Analysis of adherence challenges in the PWID population.
• Assessment of outreach testing and partnerships with support organizations.

Main Results:

• Direct-acting antiviral (DAA) therapy demonstrates high efficacy in treating HCV.
• Poor adherence to diagnosis and treatment presents a significant barrier in the PWID population.
• Outreach testing and collaboration with support organizations are effective in improving HCV diagnosis rates among PWID.

Conclusions:

• Effective HCV elimination requires innovative approaches to diagnose and treat the infection, especially in high-risk populations like PWID.
• Integrating outreach testing and community support is vital for overcoming adherence barriers and achieving HCV eradication.
• A shift in medical professional strategies is necessary to address the changing landscape of chronic hepatitis C patients.